Dr Agarwals Eye Hospital adds 32 surgical facilities in H1 FY27

Dr Agarwals Eye Hospital added 32 greenfield surgical facilities in H1'FY27, two more than the 30 it added in all of FY26, and its FY27 expansion plan provides for 55 surgical facilities. The expansion came as revenue from operations rose 28.7% year on year to Rs 1,269 crore in H1'FY27.

How many surgical facilities did DrA add in H1'FY27?

DrA added 32 greenfield surgical facilities in H1'FY27, alongside five primary facilities, taking total greenfield additions in the half year to 37. Surgical facilities in this disclosure comprise secondary and tertiary facilities, while primary facilities are shown as a separate category. DrA reported 185 greenfield facilities added since FY23.

The opening mix shifted toward surgical capacity in H1'FY27. Surgical sites accounted for 32 of the 37 greenfield additions, while primary sites accounted for five. This differed from FY26, when DrA added 57 greenfield facilities comprising 30 surgical facilities and 27 primary facilities, a more balanced split between the two formats.

How does DrA’s H1'FY27 expansion compare with earlier years?

DrA’s 32 surgical greenfield additions in H1'FY27 exceeded the 30 added during all of FY26, despite covering only the first half of the financial year. Annual surgical-facility additions were five in FY23, 13 in FY24, 20 in FY25 and 30 in FY26, showing an increasing count before H1'FY27.

Total greenfield additions reached 37 in H1'FY27, below the 57 recorded in FY26 but already above the 29 in FY24 and 10 in FY23. The H1'FY27 total was weighted to surgical locations rather than primary facilities. In FY25, 52 greenfield additions included 20 surgical and 32 primary facilities, the reverse of the H1'FY27 mix.

DrA’s total facility network rose to 324 as of September 30, 2026, from 258 in H1'FY26, a 25.6% increase. South had 200 facilities, followed by West with 55, North with 36, East with 14 and locations outside India with 19. The count includes the closure of three primary facilities in Janipur, Zirakpur and Peer Muchalla during the first two quarters of FY27.

Is DrA’s older network still growing while new sites open?

DrA reported 17.7% same-store sales growth for facilities set up or acquired up to H1'FY24, indicating that the established estate continued to grow while newer locations were added. This measure excludes revenue attributable to Elisar Life Sciences Private Limited, according to the vintage-performance disclosure.

Facilities operating from up to FY23 generated Rs 948 crore of H1'FY27 revenue from operations, representing 74.8% of the measured vintage revenue base, and grew 17.2% year on year. The FY24 vintage contributed Rs 96 crore, or 7.6%, and grew 20.9%, while the FY25 vintage contributed Rs 127 crore, or 10.0%, and grew 67.8%.

The newer estate had a smaller current revenue contribution than the mature network in H1'FY27. DrA classifies facilities as mature after more than three years of operation or ownership, and emerging before that threshold. Mature facilities accounted for 79.0% of the Rs 1,268 crore maturity-network revenue measure, while emerging facilities accounted for 21.0%; this measure excludes revenue attributable to Eris Life Sciences Private Limited.

Which regions received DrA’s H1'FY27 additions?

DrA added 18 facilities in Q1'FY27 and 21 in Q2'FY27 under its domestic expansion-plan presentation, with South and North receiving the largest disclosed additions. South added seven facilities in Q1'FY27 and 11 in Q2'FY27, while North added six in Q1'FY27 and five plus two acquired surgical facilities in Q2'FY27.

The regional operating table separately lists H1'FY27 additions of 18 facilities in South, eight in West and 13 in North, with none in East. South’s additions comprised 14 secondary and four primary facilities; West added one tertiary and seven secondary facilities; and North added two tertiary, 10 secondary and one primary facility. The expansion-plan table also identifies the two-facility Delhi NCR acquisition.

South produced Rs 791 crore of H1'FY27 regional revenue, equal to 62.4% of domestic disclosed revenue and up 24.6% year on year. North was smaller at Rs 115 crore and 9.0% contribution, but recorded the fastest regional revenue growth at 59.9%. North also reported 90.0% growth in patients served to 2,61,102 and 41.8% growth in surgeries to 20,219.

What is DrA planning for the rest of FY27?

DrA plans 65 facility additions for FY27, including 55 surgical facilities, according to its expansion plan. After 18 additions in Q1'FY27 and 21 in Q2'FY27, the plan indicates 26 additions in H2'FY27, of which 21 are expected to be surgical facilities. The H2'FY27 and FY27 total figures are marked as estimates.

The FY27 plan allocates 25 facilities to South, 20 to North, 15 to West and five to East. Surgical facilities make up 55 of the planned 65 additions, compared with 30 surgical facilities out of 56 domestic openings in FY26. DrA also plans to add a facility in Zambia and enter Ethiopia alongside its expansion in India.

Operating volumes increased during the first half of FY27. Surgeries performed rose 18.8% to 1,86,923 in H1'FY27, led by cataract procedures, which increased from 1,14,640 to 1,37,170. Patients served rose 28.5% to 18,43,809, while doctor count increased from 881 to 1,111 as of September 30, 2026.

Conclusion

DrA’s H1'FY27 network build concentrated on surgical locations: its 32 surgical greenfield additions surpassed FY26’s full-year total of 30, while it added five primary facilities. At the same time, facilities open or acquired up to H1'FY24 delivered 17.7% same-store sales growth, and mature facilities supplied 79.0% of the disclosed maturity-network revenue base.

The next disclosed milestone is execution of the H2'FY27 estimate of 26 additional facilities, including 21 surgical sites, toward the FY27 plan of 65 facilities and 55 surgical facilities. DrA also plans a Zambia facility and entry into Ethiopia, while North’s H1'FY27 revenue growth was 59.9% as its network expanded.